| JOHNSON & JOHNSON (J&J) |
| USA |
| Gesundheit |
| US4781601046 / 853260 |
| JNJ (Frankfurt) / JNJ (NYSE) |
| FRA:JNJ, ETR:JNJ, JNJ:GR, NYSE:JNJ |
| https://www.jnj.com/ |
|
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, focu..
>Volltext.. |
| 516625.89 Mio. EUR |
| 541713.02 Mio. EUR |
| 81235.58 Mio. EUR |
| 28573.77 Mio. EUR |
| 23117.76 Mio. EUR |
| 9.6 EUR |
| 42548.44 Mio. EUR |
| 16998.5 Mio. EUR |
| 21156.49 Mio. EUR |
| 0.37 |
| -6.53% |
| 67.96% |
| 4.46 EUR |
| 2.09% |
| 2.09% |
| 24.02.26 - 1.1031799€ 25.11.25 - 1.12814€ >weitere anzeigen... |
| 6 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 58.353.447 USD. |
| JOHNSON & JOHNSON, J&J, JOHNSON&JOHNSON, JOHNSONJOHNSON, JNJ, JOHNSON AND JOHNSON, JOHNSON JOHNSON |
| 04.03.26 |
|
||||
|